RiteMED Montelukast Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Montelukast Na

Indications/Uses

Management of chronic asthma. Relief of symptoms of allergic rhinitis. Prophylaxis & chronic treatment of asthma. Prevention of exercise-induced bronchoconstriction.

Click to view RiteMED Montelukast detailed prescribing information

Dosage/Direction for Use

Adult & childn ≥15 yr Two 5-mg tab daily or one 10-mg tab daily. Childn 6-14 yr 5 mg once daily.

Click to view RiteMED Montelukast detailed prescribing information

Overdosage

View RiteMED Montelukast overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity.

Click to view RiteMED Montelukast detailed prescribing information

Special Precautions

Not indicated for treatment of acute asthma attacks including status asthmaticus. Avoid concomitant use w/ aspirin or NSAIDs in patients w/ known aspirin sensitivity. Monitor neuropsychiatric events. Eosinophilic conditions may occur. Pregnancy & lactation. Infants <6 mth.

Click to view RiteMED Montelukast detailed prescribing information

Use In Pregnancy & Lactation

Click to view RiteMED Montelukast detailed prescribing information

Adverse Reactions

URTI, fever, headache, pharyngitis, cough, abdominal pain, diarrhea, otitis media, flu, rhinorrhea, sinusitis, & otitis.

Click to view RiteMED Montelukast detailed prescribing information

Drug Interactions

Aspirin or other NSAIDs. Decreased AUC w/ phenobarb. Concomitant use w/ potent CYP450 enzyme inducers eg, phenytoin, rifampicin.

Click to view RiteMED Montelukast detailed prescribing information

Storage

View RiteMED Montelukast storage conditions for details to ensure optimal shelf-life.

Description

View RiteMED Montelukast description for details of the chemical structure and excipients (inactive components).

Action

View RiteMED Montelukast mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03DC03 - montelukast ; Belongs to the class of leukotriene receptor antagonists. Used in the systemic treatment of obstructive airway diseases.

Regulatory Classification

Presentation/Packing

Form

RiteMED Montelukast tab 10 mg

Packing/Price

28's (P896/box, P32/tab)

Form

RiteMED Montelukast tab 5 mg

Packing/Price

28's (P616/box, P22/tab)

RiteMED Montelukast

montelukast

Manufacturer:

RiteMED

Distributor:

RiteMED